Consumer interest in CBD products is on a rapid rise, as many turn to relatively new hemp products with little-to-no THC (a psychotropic compound found in cannabis) seeking to address everything from skin care issues to anxiety, medical ailments and even pet health.
Despite growing demand, the CBD industry operates with limited regulation and a lack of meaningful standards and oversight. In fact, a study released by Portland-based LegitScript shows significant gaps in product claims and the presence of dangerous substances in some products. The study highlights problematic business processes, including website noncompliance and troubling financial practices.
Key findings include:
“There are many legitimate CBD providers in the market, but they are overshadowed by troublesome players with suspect products and business practices. At a certain point, rampant noncompliance can lead to a devastating loss of consumer trust," John Horton, LegitScript's President and CEO, told Benzinga. “For the CBD market to grow and thrive, the issues uncovered in this study must be addressed. Certification and monitoring will go a long way to help the industry gain the legitimacy it seeks.”
Company in compliance for CBD products New World CBD
Read more: feedproxy.google.com